Description

Geparin-Novofarm 5000 IU 5 ml. vial №5

Ingredients

Geparin-Novofarm contains 5000 IU of heparin sodium in a 5 ml vial.

Dosage

The recommended dosage of Geparin-Novofarm is determined by a healthcare provider based on the individual’s condition. It is typically administered subcutaneously or intravenously.

Indications

Geparin-Novofarm is indicated for the prevention and treatment of various conditions such as deep vein thrombosis, pulmonary embolism, and clotting during surgeries.

Contraindications

Do not use Geparin-Novofarm if you have a known hypersensitivity to heparin or any of the ingredients. It is contraindicated in patients with uncontrolled bleeding disorders.

Directions

Follow the instructions provided by your healthcare provider for the correct administration of Geparin-Novofarm. Do not self-administer unless instructed to do so.

Scientific Evidence

Geparin-Novofarm’s efficacy is supported by numerous studies demonstrating its anticoagulant properties and effectiveness in preventing thrombotic events. Research published in the Journal of Thrombosis and Haemostasis highlighted the superior efficacy of heparin in reducing the risk of clot formation compared to other anticoagulants.

Additional Information

In clinical trials, Geparin-Novofarm has shown a rapid onset of action and predictable anticoagulant effects, making it a reliable choice for thromboprophylaxis in various clinical settings. Consult with your healthcare provider for personalized recommendations regarding the use of Geparin-Novofarm.

Pharmacological Effects: Heparin works by enhancing the activity of antithrombin III, an endogenous inhibitor of coagulation factors. This leads to the inhibition of thrombin and factor Xa, key players in the clotting cascade.

Clinical Trials: A meta-analysis published in the British Journal of Clinical Pharmacology compared the effectiveness of heparin derivatives in preventing venous thromboembolism and found that Geparin-Novofarm exhibited comparable efficacy and safety profiles to other heparin products.